CS logo
small CS logo
Baylor College of Medicine / Texas Children's Hospital

Houston, Texas, United States
Hospital in Houston, Texas
6621 Fannin St, Houston, TX 77030
973 Beds

About Baylor College of Medicine / Texas Children's Hospital


Texas Children's Hospital is a nationally ranked, freestanding 973-bed, acute care women's and children's hospital located in Houston, Texas. It is affiliated with Baylor College of Medicine and is located within the Texas Medical Center.
There are 973 beds in Baylor College of Medicine / Texas Children's Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
27
Baylor College of Medicine
18
Therapeutic Advances in Childhood Leukemia Consortium
5
University of North Carolina, Chapel Hill
5
Aimmune Therapeutics, Inc.
4
Allergan
4
Arbor Research Collaborative for Health
4
DBV Technologies
4
HealthCore-NERI
4
Novartis Pharmaceuticals
4
Children's Hospital Medical Center, Cincinnati
3
Total Rows: 90

Clinical Trials at Baylor College of Medicine / Texas Children's Hospital


During the past decade, Baylor College of Medicine / Texas Children's Hospital conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 42 clinical trials were completed, i.e. on average, 53.2% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 21 clinical trials were completed. i.e. 84% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years131399202055778899553322445555557712122200Started TrialsCompleted Trails2015201620172018201920202021202220230102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children
1996-09-01
Completed
819
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
Completed
30
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection
Completed
18
An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
Completed
660
A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
1993-04-01
Completed
250
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
2007-08-01
Completed
1,600
A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
2001-11-01
Completed
690
A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease
1998-11-01
Completed
390

Rows per page:

1–100 of 178

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Baylor College of Medicine / Texas Children's Hospital" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 27 trials, followed by "Baylor College of Medicine" with 18 trials sponsored, "Therapeutic Advances in Childhood Leukemia Consortium" with 5 trials sponsored, "University of North Carolina, Chapel Hill" with 5 trials sponsored and "Aimmune Therapeutics, Inc." with 5 trials sponsored. Other sponsors include 114 different institutions and companies that sponsored additional 90 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor College of Medicine / Texas Children's Hospital" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 15 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 10 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 9 trials as a collaborator, "Baylor College of Medicine" with 8 trials as a collaborator and "National Institutes of Health (NIH)" with 7 trials as a collaborator. Other collaborators include 168 different institutions and companies that were collaborators in the rest 128 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational Institute ofAllergy and InfectiousDiseases (NIAID): 27National Institute ofAllergy and InfectiousDiseases (NIAID): 27Baylor College of Medicine: 18Baylor College of Medicine: 18Therapeutic Advancesin Childhood LeukemiaConsortium: 5Therapeutic Advancesin Childhood LeukemiaConsortium: 5University of NorthCarolina, Chapel Hill: 5University of NorthCarolina, Chapel Hill: 5Aimmune Therapeutics, Inc.: 4Aimmune Therapeutics, Inc.: 4Allergan: 4Allergan: 4Arbor ResearchCollaborative forHealth: 4Arbor ResearchCollaborative forHealth: 4DBV Technologies: 4DBV Technologies: 4HealthCore-NERI: 4HealthCore-NERI: 4Novartis Pharmaceuticals: 4Novartis Pharmaceuticals: 4

Created with Highcharts 11.1.0Top CollaboratorsEunice Kennedy ShriverNational Institute ofChild Health and HumanDevelopment (NICHD):15Eunice Kennedy ShriverNational Institute ofChild Health and HumanDevelopment (NICHD):15National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 10National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 10National Heart, Lung,and Blood Institute(NHLBI): 9National Heart, Lung,and Blood Institute(NHLBI): 9Baylor College of Medicine: 8Baylor College of Medicine: 8National Institutes ofHealth (NIH): 7National Institutes ofHealth (NIH): 7Bristol-Myers Squibb: 5Bristol-Myers Squibb: 5Children's HospitalMedical Center,Cincinnati: 5Children's HospitalMedical Center,Cincinnati: 5Glaxo Wellcome: 5Glaxo Wellcome: 5Nationwide Children's Hospital: 5Nationwide Children's Hospital: 5Cystic Fibrosis Foundation: 4Cystic Fibrosis Foundation: 4

Clinical Trials Conditions at Baylor College of Medicine / Texas Children's Hospital


According to Clinical.Site data, the most researched conditions in "Baylor College of Medicine / Texas Children's Hospital" are "HIV Infections" (27 trials), "Peanut Allergy" (8 trials), "Cystic Fibrosis" (6 trials), "Sickle Cell Disease" (6 trials) and "Biliary Atresia" (5 trials). Many other conditions were trialed in "Baylor College of Medicine / Texas Children's Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Baylor College of Medicine / Texas Children's Hospital


Most popular intervention types in "Baylor College of Medicine / Texas Children's Hospital" are "Drug" (81 trials), "Other" (32 trials), "Biological" (21 trials), "Device" (9 trials) and "Dietary Supplement" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Zidovudine" (10 trials), "Didanosine" (7 trials), "Nevirapine" (5 trials) and "AR101" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Baylor College of Medicine / Texas Children's Hospital


The vast majority of trials in "Baylor College of Medicine / Texas Children's Hospital" are 169 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at Baylor College of Medicine / Texas Children's Hospital


Currently, there are 56 active trials in "Baylor College of Medicine / Texas Children's Hospital". 2 are not yet recruiting, 31 are recruiting, 21 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 102 completed trials in Baylor College of Medicine / Texas Children's Hospital, 1 suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Baylor College of Medicine / Texas Children's Hospital, 21 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 28 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 44Phase 3: 44Phase 2: 40Phase 2: 40Not Applicable: 28Not Applicable: 28Phase 1: 21Phase 1: 21Phase 4: 3Phase 4: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 102Completed: 102Recruiting: 31Recruiting: 31Active, not recruiting: 21Active, not recruiting: 21Terminated: 10Terminated: 10Unknown status: 5Unknown status: 5Available: 3Available: 3Enrolling by invitation: 2Enrolling by invitation: 2Not yet recruiting: 2Not yet recruiting: 2Suspended: 1Suspended: 1Withdrawn: 1Withdrawn: 1